DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

AbbVie Inc. (NYSE: ABBV)

68.06 0.28 (0.41%)

REAL-TIME: Last trade at

Extended Hours: $68.06 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

ABBV $68.06 0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.64
Previous Close $67.78
Daily Range $67.15 - $68.21
52-Week Range $45.50 - $68.21
Market Cap $108.4B
P/E Ratio 29.47
Dividend (Yield) $1.96 (2.9%)
Ex-Dividend Date
Dividend Pay Date
01/13/15
02/13/15
Volume 7,349,853
Average Daily Volume 15,876,277
Current FY EPS $3.29

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie

Gilead Sciences hepatitis C drug Harvoni offers three important advantages over AbbVie's competing hepatitis C drug cocktail.

AbbVie Takes Aim at Gilead Sciences

AbbVie has won support from a key advisory committee for its new hepatitis C drug cocktail.

Be Careful With Gilead - It May Be Time To Take Profits

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2014 Update

AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog

Novo Nordisk's Victoza Recommended for Label Expansion - Analyst Blog

Sanofi's (SNY) Cerdelga a Step Closer to European Approval - Analyst Blog

Fast Money Halftime Report Final Trade From November 24

Can Partnering To Fight Hepatitis C Pay At Enanta?

Dividend Aristocrats In Focus Part 45: AbbVie

See More ABBV News...